Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Thoracic Cancer|March 12, 2020
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse eventsYu Miura, Atsuto Mouri, Kyoichi Kaira, et al.Anticancer Research|January 25, 2023
Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node MetastasisTakanori Abe, Misaki Iino, Satoshi Saito, et al.Anticancer Research|January 31, 2025
Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung CancerAkira Matsukida, Hisao Imai, Ayako Shiono, et al.Radiology and Oncology|September 17, 2024
A retrospective evaluation of therapeutic efficacy and safety of chemoradiotherapy in older patients (aged ≥ 75 years) with limited-disease small cell lung cancer: insights from two institutions and review of the literatureAyako Shiono, Hisao Imai, Satoshi Endo, et al.Journal of Radiation Research|September 23, 2025
Characteristics of cardiac toxicity after definitive radiation therapy for thoracic esophageal cancer in Japanese patientsKeita Tsukahara, Takanori Abe, Satoshi Saito, et al.Cancer Science|July 22, 2017
Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neckKatsuyuki Shirai, Jun-Ichi Saitoh, Atsushi Musha, et al.Scientific Reports|June 19, 2019
A landmark in drug discovery based on complex natural product synthesisSatoshi Kawano, Ken Ito, Kenzo Yahata, et al.Thoracic Cancer|June 30, 2025
Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective StudyAyako Shiono, Hisao Imai, Kyoichi Kaira, et al.Cancer Research Communications|July 10, 2024
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W-L Eng, Yu Kato, Yusuke Adachi, et al.Pageof 8